3Robert V, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure function and biochemistry [J]. Circ Res, 2003, 92:827 -839.
2Zhang BP, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gen in relation to severity of coronary atherosclerosis. Circulation, 1999,99:1788-1794.
3Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atheroslerotic plaque rupture. Cardiovasc-Res, 1999,41 :361-368.
4Rekhter MD, Hicks GW, Brammer DW, et al. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: local collagen loss as a prerequisite of plaque rupture. Cire-Res ,2000,86 : 101-108.
5Xu XP, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalliproteianse-9 and its tissue inhibitor in human monocyte-derived macrophage. Circulation, 1999 24:993-998.
6Mach F, Schonbeck U,Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Circulation, 1997,96:396-399.
7PARSONS SL, WATSON SA, BROWN PD, et al. Matrix metalloproteinases [J]. Br J Surg, 1997, 84 (2):160- 166.
8BAKER AH, ZALTSMAN AB, GEORGE SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase - 1,- 2, or - 3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro, TIMP - 3 promotes apoptosis [J]. J Clin Invest, 1998, 101 (6):1478- 1487.
9GREENE J, WANG M, LIU YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase- 4 [J]. J Biol Chem, 1996, 271(48) : 30375 - 30380.
10STEINMANN - NIGGLI K, ZTSWILER R, KUNG M,et al. Inhibition of matrix metalloproteinases attenuates anti- Thy1. 1 nephritis [J ]. J Am Soc Nephrol,1998, 9 (3): 397-407.
3TEPPER OM, GALIANO RD, CAPLA JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures [J]. Circulation, 2002, 106: 2781-2786.
4ISABELLE P, DAVID J, SHAHIN R, The SDF-1/CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis[J]. Trends Immunol, 2007, 28: 299-307.
5POZNANSKY MC, OLSZAK IT, FOXALL R, et aL Active movement of T cells away from a chemokine[J]. Nature Medicine, 2000, 6: 543-548.
6BUTLER JM, GUTHRIE SM, KOC M, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy [J]. J Clin Invest, 2005, 115: 86-93.
7DANDONA P, ALJADA A, MOHANTT P, et al. Insulin suppresses plasma concentration of vascular endothelia/ growth factor and matrix metalioproteinase-9 [J]. Diabetes Care, 2003, 26: 3310-3314.
8FADINI GP, MIORIN M, FACCO M. et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus [J]d am coll Cardiol, 2005, 45: 1449-1457.
